Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill
Status:
Unknown status
Trial end date:
2017-10-13
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to compare the adjunct treatment of metabolic or mixed
severe acidosis in the critically ill using Sodium Bicarbonate as a buffer to increase the
plasma pH vs no buffering therapy.
The study is a randomized multiple center clinical trial with the outcome as a primary
endpoint.